Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/ANI Pharmaceuticals, Inc./ 10-Q

Quarterly Report · 10-Q

ANI Pharmaceuticals, Inc.

ANIPNASDAQEQUITYCurrent

Quarterly Report

Filed Aug 7, 2026Accepted Aug 7, 2026, 7:01 AM EDTCIK 1023024Accession 0001023024-26-000069
View company →Permanent SEC source ↗
Share

Company context

Current securities

ANIPNASDAQ · EQUITY · Current

Recent company filings

  1. 144 filingSep 15, 2026
  2. 144 filingSep 11, 2026
  3. 4 filingAug 27, 2026
  4. 144 filingAug 25, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 24, 2026

As-filed source

Primary evidence
As filedOpen full document ↗